AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MediWound Ltd.

$13.11 -$5.31 (-28.83%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$13.71
Day Range
$12.95$13.81
Year Range
$12.52$20.03
Market Cap
168.41M
AVG Volume
93.32K
Trailing/Forward PE
-8.19/-
PEG ratio
-26.41
Dividend Yield
-
Next Earnings Date
2026-11-19
Primary Exchange
NASDAQUS
Revenue (USD)
010M20M30M40M2016201720182019202020212022202320242025
MDWD Revenue (USD) by year
PeriodRevenue (USD)
202516.96M
202420.22M
202318.69M
202226.5M
202123.76M
202021.76M
201931.79M
20183.4M
20172.5M
20161.56M
Net Income (USD)
-40M-30M-20M-10M010M2016201720182019202020212022202320242025
MDWD Net Income (USD) by year
PeriodNet Income (USD)
2025-23.88M
2024-30.22M
2023-6.72M
2022-19.6M
2021-13.55M
2020-9.2M
20194.96M
2018-1.06M
2017-22.15M
2016-18.89M
Operating Income (USD)
-30M-20M-10M010M2016201720182019202020212022202320242025
MDWD Operating Income (USD) by year
PeriodOperating Income (USD)
2025-25.28M
2024-19.38M
2023-15.29M
2022-8.35M
2021-11.22M
2020-8.84M
20194.49M
2018-3.96M
2017-13.69M
2016-20.16M
EBITDA (USD)
-30M-20M-10M010M2016201720182019202020212022202320242025
MDWD EBITDA (USD) by year
PeriodEBITDA (USD)
2025-12.61M
2024-27.35M
20232.58M
2022-18M
2021-11.3M
2020-7.01M
20194.2M
2018-4.31M
2017-13.11M
2016-17.29M
Cash Flows (USD)
-30M-20M-10M010M2016201720182019202020212022202320242025
MDWD Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-21.63M
2024-19.29M
2023-16.05M
2022-12.44M
2021-9.44M
2020-7.82M
20196.98M
2018-12.69M
2017-17.53M
2016-17.15M
EPS (USD)
-7.5-5-2.502.52016201720182019202020212022202320242025
MDWD EPS (USD) by year
PeriodEPS (USD)
2025-2.1
2024-3.07
2023-0.77
2022-3.85
2021-3.45
2020-2.34
20191.29
2018-0.29
2017-6.84
2016-6.03
Expenses (USD)
010M20M30M40MR&DSG&ACapex2016201720182019202020212022202320242025
MDWD Expenses (USD) by year
PeriodExpenses (USD)
202533.75M
202428.06M
202325.25M
202220.81M
202120.24M
202017.2M
201915.27M
201812.55M
201715.62M
201620.19M
Cash & Debt (USD)
020M40M60M2016201720182019202020212022202320242025
MDWD Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202553.14M
20249.15M
202341.54M
202233.9M
202111.05M
202021.4M
201929.28M
201823.63M
201736.07M
201630.03M
Debt ratios
00.511.520182019202020212022202320242025
MDWD Debt ratios by year
PeriodDebt ratios
20250.81
20240.05
20231.04
20221.03
20210.52
20200.97
20190.89
20180.44
Margins
-50%0%50%100%2016201720182019202020212022202320242025
MDWD Margins by year
PeriodMargins
202519.19%
202413.03%
202319.15%
202249.69%
202136.91%
202034.67%
201964.13%
201838.61%
201736.78%
2016-38.51%
Return on Capital
-400%-200%0%200%400%2016201720182019202020212022202320242025
MDWD Return on Capital by year
PeriodReturn on Capital
2025-54.73%
2024-97.02%
2023-21.26%
2022-179.58%
2021295.74%
2020-126.46%
201932.67%
2018-11.78%
2017-230.24%
2016-243.05%
Shares Outstanding
05M10M15M2016201720182019202020212022202320242025
MDWD Shares Outstanding by year
PeriodShares Outstanding
202512.83M
202410.79M
20239.22M
20226.33M
20213.89M
20203.89M
20193.88M
20183.87M
20173.86M
20163.13M
Book Value Per Share (USD)
-20242016201720182019202020212022202320242025
MDWD Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20253.4
20242.89
20233.43
20221.72
2021-1.18
20201.87
20193.91
20182.32
20172.49
20162.48
Total Assets (USD)
025M50M75M100M2016201720182019202020212022202320242025
MDWD Total Assets (USD) by year
PeriodTotal Assets (USD)
202586.25M
202473.5M
202366.46M
202250.02M
202119.74M
202031.07M
201940.59M
201835.28M
201744.13M
201635.76M
Employee Count
0501001502016201720182019202020212022202320242025
MDWD Employee Count by year
PeriodEmployee Count
2025121
2024111
202388
202273
202167
202065
201962
201861
201760
201654
PE Ratio
05101520med 5.26Aug 19Oct 19Dec 19Feb 20Apr 20Jun 20Jul 20
MDWD PE Ratio by year
PeriodPE Ratio
Jul 2016.15
Jul 2017.02
Jul 2015.12
Jul 2014.5
Jul 2013.88
Jun 2011.04
Jun 2011.21
Jun 207.91
Jun 208.59
May 208.45
May 208.32
May 2010.59
May 2010.81
May 2010.97
Apr 2010.42
Apr 2010.92
Apr 208.78
Apr 208.04
Mar 209.05
Mar 208.72
Mar 2011.57
Mar 2013.55
Feb 2015.2
Feb 204.26
Feb 204.25
Feb 204.29
Jan 204.33
Jan 204.36
Jan 204.33
Jan 204.33
Jan 204.36
Dec 194.32
Dec 194.34
Dec 194.43
Dec 194.09
Nov 194.28
Nov 194.29
Nov 194.36
Nov 195.01
Nov 194.88
Oct 194.65
Oct 194.68
Oct 194.98
Oct 195.03
Sep 195.15
Sep 195.51
Sep 195.36
Sep 195.08
Aug 195.26
Aug 195.03
Aug 194.53
Free Cash Flow Yield
-17.5%-15%-12.5%-10%-7.5%med -10.19%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDWD Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-16.81%
Sep 26-16.58%
Aug 26-17.4%
Aug 26-16.68%
Aug 26-16.25%
Aug 26-13.57%
Jul 26-13.82%
Jul 26-13.72%
Jul 26-13.36%
Jul 26-13.66%
Jul 26-12.88%
Jun 26-12.85%
Jun 26-13.71%
Jun 26-13.73%
Jun 26-13.77%
May 26-11.77%
May 26-10.17%
May 26-10.28%
May 26-10.18%
May 26-10.14%
Apr 26-10.08%
Apr 26-9.52%
Apr 26-9.45%
Apr 26-10.03%
Mar 26-11.2%
Mar 26-9.94%
Mar 26-10.17%
Mar 26-9.9%
Feb 26-9.75%
Feb 26-9.44%
Feb 26-9.77%
Feb 26-9.49%
Jan 26-9.31%
Jan 26-9.53%
Jan 26-10.38%
Jan 26-9.02%
Jan 26-9.16%
Dec 25-8.98%
Dec 25-8.99%
Dec 25-8.86%
Dec 25-9.54%
Nov 25-9.42%
Nov 25-9.89%
Nov 25-9.74%
Nov 25-10.13%
Oct 25-9.7%
Oct 25-9.64%
Oct 25-9.46%
Oct 25-9.79%
Oct 25-10.34%
Sep 25-9.94%
Sep 25-10.47%
Sep 25-9.97%
Sep 25-10.91%
Aug 25-10.65%
Aug 25-10.1%
Aug 25-9.82%
Aug 25-9.88%
Aug 25-9.94%
Jul 25-9.06%
Jul 25-9%
Jul 25-9.19%
Jul 25-9.52%
Jun 25-9.56%
Jun 25-9.65%
Jun 25-9.02%
Jun 25-8.52%
May 25-8.39%
May 25-9.04%
May 25-8.73%
May 25-10.2%
May 25-10.36%
Apr 25-9.89%
Apr 25-10.45%
Apr 25-10.92%
Apr 25-11.94%
Mar 25-11.21%
Mar 25-10.99%
Mar 25-10.67%
Mar 25-11.69%
Feb 25-11.92%
Feb 25-11.19%
Feb 25-10.55%
Feb 25-10.91%
Jan 25-10.11%
Jan 25-9.98%
Jan 25-11.22%
Jan 25-11.83%
Jan 25-11%
Dec 24-11.18%
Dec 24-12%
Dec 24-11.44%
Dec 24-11.66%
Nov 24-11.33%
Nov 24-13.59%
Nov 24-14%
Nov 24-12.96%
Nov 24-12.19%
Oct 24-12.82%
Oct 24-12.74%
Price to Sales
6810121416med 9.9Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDWD Price to Sales by year
PeriodPrice to Sales
Sep 2614.24
Sep 2614.43
Aug 2613.75
Aug 2614.35
Aug 2614.73
Aug 2612.79
Jul 2612.55
Jul 2612.65
Jul 2612.99
Jul 2612.71
Jul 2613.48
Jun 2613.51
Jun 2612.66
Jun 2612.64
Jun 2612.61
May 2610.84
May 2612.54
May 2612.41
May 2612.53
May 2612.58
Apr 2612.64
Apr 2613.4
Apr 2613.5
Apr 2612.71
Mar 2611.38
Mar 2612.83
Mar 2612.54
Mar 2612.88
Feb 269.11
Feb 269.41
Feb 269.09
Feb 269.37
Jan 269.55
Jan 269.32
Jan 268.56
Jan 269.85
Jan 269.7
Dec 259.89
Dec 259.88
Dec 2510.03
Dec 259.31
Nov 259.44
Nov 258.98
Nov 259.96
Nov 259.58
Oct 2510
Oct 2510.06
Oct 2510.26
Oct 259.91
Oct 259.38
Sep 259.76
Sep 259.26
Sep 259.73
Sep 258.89
Aug 259.11
Aug 259.61
Aug 259.88
Aug 2510.06
Aug 2510
Jul 2510.98
Jul 2511.05
Jul 2510.81
Jul 2510.44
Jun 2510.4
Jun 2510.31
Jun 2511.02
Jun 2511.66
May 2511.85
May 2511
May 2510.93
May 259.35
May 259.21
Apr 259.65
Apr 259.13
Apr 258.74
Apr 257.99
Mar 258.51
Mar 258.68
Mar 259.88
Mar 259.02
Feb 258.85
Feb 259.42
Feb 2510
Feb 259.66
Jan 2510.44
Jan 2510.57
Jan 259.4
Jan 258.91
Jan 259.59
Dec 249.43
Dec 248.79
Dec 249.22
Dec 249.05
Nov 249.31
Nov 247.59
Nov 247.37
Nov 247.97
Nov 248.46
Oct 248.05
Oct 248.1
EV/EBITDA
020406080med 5.63Sep 19Dec 19Feb 20May 20Jul 20May 24Aug 24
MDWD EV/EBITDA by year
PeriodEV/EBITDA
Aug 2453.53
Aug 2451.5
Jul 2459.74
Jul 2455.48
Jul 2464.58
Jul 2459.03
Jun 2444.54
Jun 2437.22
Jun 2442.62
Jun 2449.94
May 2447.34
May 2444.93
May 2447.04
May 2448.26
May 2453.01
Apr 2451.54
Apr 2442.72
Apr 2443.5
Apr 2440.36
Mar 2437.28
Mar 2443.43
Jul 2014.14
Jul 2015.14
Jul 2012.96
Jul 2012.25
Jul 2011.54
Jun 208.27
Jun 208.46
Jun 204.67
Jun 205.45
May 205.29
May 205.14
May 206
May 206.25
May 206.45
Apr 205.8
Apr 206.38
Apr 203.87
Apr 202.99
Mar 204.18
Mar 203.8
Mar 207.16
Mar 209.49
Feb 2011.43
Feb 203.91
Feb 203.88
Feb 203.95
Jan 204.01
Jan 204.05
Jan 204.01
Jan 204.01
Jan 204.05
Dec 193.99
Dec 194.02
Dec 194.16
Dec 193.65
Nov 193.93
Nov 193.95
Nov 194.05
Nov 193.42
Nov 193.25
Oct 192.96
Oct 193.01
Oct 193.38
Oct 193.44
Sep 193.59
Sep 194.04
Sep 193.85
Sep 193.5
Aug 193.73
Aug 193.44
Aug 192.82
Price/Operating Cashflow
57.51012.515med 7.38Aug 19Oct 19Dec 19Feb 20Apr 20Jun 20Jul 20
MDWD Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Jul 2013.66
Jul 2014.39
Jul 2012.78
Jul 2012.26
Jul 2011.74
Jun 209.34
Jun 209.47
Jun 206.69
Jun 207.27
May 207.14
May 207.04
May 206.75
May 206.89
May 207
Apr 206.65
Apr 206.96
Apr 205.6
Apr 205.13
Mar 205.77
Mar 205.56
Mar 207.38
Mar 208.64
Feb 209.69
Feb 209.39
Feb 209.36
Feb 209.45
Jan 209.54
Jan 209.61
Jan 209.54
Jan 209.54
Jan 209.61
Dec 199.51
Dec 199.55
Dec 199.76
Dec 199.01
Nov 199.42
Nov 199.45
Nov 199.61
Nov 196.75
Nov 196.57
Oct 196.25
Oct 196.3
Oct 196.7
Oct 196.77
Sep 196.94
Sep 197.42
Sep 197.22
Sep 196.84
Aug 197.08
Aug 196.77
Aug 196.1
Price to Book
24681012med 5.34Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDWD Price to Book by year
PeriodPrice to Book
Sep 264.74
Sep 264.8
Aug 264.58
Aug 264.77
Aug 264.9
Aug 264.47
Jul 264.39
Jul 264.42
Jul 264.54
Jul 264.44
Jul 264.71
Jun 264.72
Jun 264.43
Jun 264.42
Jun 264.41
May 264.21
May 264.87
May 264.82
May 264.87
May 264.89
Apr 264.91
Apr 265.21
Apr 265.25
Apr 264.94
Mar 264.42
Mar 264.99
Mar 264.87
Mar 265.01
Feb 263.8
Feb 263.93
Feb 263.8
Feb 263.91
Jan 263.98
Jan 263.89
Jan 263.57
Jan 264.11
Jan 264.05
Dec 254.13
Dec 254.12
Dec 254.19
Dec 253.89
Nov 253.94
Nov 253.75
Nov 259.83
Nov 259.46
Oct 259.87
Oct 259.93
Oct 2510.12
Oct 259.79
Oct 259.26
Sep 259.63
Sep 259.14
Sep 259.61
Sep 258.77
Aug 258.99
Aug 259.48
Aug 259.75
Aug 256.18
Aug 256.15
Jul 256.74
Jul 256.79
Jul 256.64
Jul 256.41
Jun 256.39
Jun 256.33
Jun 256.77
Jun 257.16
May 257.28
May 256.76
May 257.09
May 256.07
May 255.98
Apr 256.26
Apr 255.92
Apr 255.67
Apr 255.19
Mar 255.52
Mar 255.64
Mar 255.69
Mar 255.2
Feb 255.1
Feb 255.43
Feb 255.76
Feb 255.57
Jan 256.01
Jan 256.09
Jan 255.42
Jan 255.13
Jan 255.52
Dec 245.43
Dec 245.06
Dec 245.31
Dec 245.21
Nov 245.36
Nov 248.56
Nov 248.31
Nov 248.98
Nov 249.54
Oct 249.08
Oct 249.13
MediWound Ltd.
MDWD
Stockpicker

Video analysis: MDWD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MDWD

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

globenewswire.com · 2 Sep 2026

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

MediWound to Present at the H.C. Wainwright 28 th Annual Global Investment Conference YAVNE, Israel, September 2, 2026 -- MediWound Ltd.

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

MediWound Q2 Earnings Call Highlights

marketbeat.com · 13 Aug 2026

MediWound Q2 Earnings Call Highlights

MediWound NASDAQ: MDWD reported second-quarter 2026 revenue of $3.1 million, down from $5.7 million a year earlier, as the company continued investing in its Phase III EscharEx chronic-wound program and expanded development work around its NexoBrid burn treatment.

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates

zacks.com · 13 Aug 2026

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates

MediWound (MDWD) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $1.23 per share a year ago.

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

globenewswire.com · 13 Aug 2026

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

EscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid ® Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed Conference Call Today at 8:30 a.m. Eastern Time YAVNE, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd.

MediWound to Report Second Quarter 2026 Financial Results

globenewswire.com · 29 Jul 2026

MediWound to Report Second Quarter 2026 Financial Results

MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time YAVNE, Israel, July 29, 2026 -- MediWound Ltd.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.